Fred Hutch Cancer Center scientists have developed an experimental strategy to give genetically engineered CAR T cells help they'd normally find within lymph nodes — but on the go, within the tumor.
Clinical-stage immuno-oncology company Imugene Ltd (ASX:IMU, OTC:IUGNF, FRA:ILA) has reported encouraging early response ...
The MarketWatch News Department was not involved in the creation of this content. Neuroendocrine Carcinoma Market Poised for Significant Growth During the Forecast Period (2026-2036) Driven by Rising ...
Aggregating ‘negative’ immunotherapy trials can uncover reproducible immune perturbations that are missed in single studies, reframing lack of clinical benefit as potentially informative biologic ...
A team of University of Kentucky researchers has uncovered a surprising clue in the battle against Alzheimer's disease that could help doctors predict, and ultimately prevent, a common side effect of ...
The neuroendocrine carcinoma market is experiencing steady growth driven by rising disease prevalence and improved diagnostic capabilities. Advancements in targeted therapies and immunotherapies ...
Inside each of your cells lies a nucleus, its master command center. Protected inside each nucleus are your chromosomes, ...
The Hematologic Malignancies Market is projected to grow from USD 72,200.85 million in 2024 to USD 128,481.41 million by 2032 ...
Improving the gap between your biological age and your chronological age is associated with a lower risk of stroke and improvements in signs of damage in the brain, according to a preliminary study ...
Individuals share their journeys battling cancer and their experiences with groundbreaking immunotherapy treatments.
Let's unpack the facts and do away with the stigma.
The hourlong program "Why Can't We Cure Cancer? A National Conversation" comes as a follow-up to NewsNation's November ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results